IDG-Accel China Growth Fund GP III Associates Ltd., 10% Owner, Director at CASI Pharmaceuticals, Inc. (CASI), bought 6,172,836 shares at $3.19 ($19.7M) on 2018-03-21, disclosed to the SEC on 2018-03-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.19 | 204,320 | $652K | 3.3% |
| 2 | $3.19 | 204,320 | $652K | 3.3% |
| 3 | $3.19 | 2,882,098 | $9.2M | 46.7% |
| 4 | $3.19 | 2,882,098 | $9.2M | 46.7% |
| Total | $3.19 avg | 6,172,836 | $19.7M | 100% |